A Phase II study of preoperative concurrent chemoradiotherapy with TS-1 in patients with locally advanced lower rectal cancer.

Phase 2

Recruiting

• Conditions: ocally-advanced lower rectal cancer

• Registration Number: JPRN-UMIN000006242
• Lead Sponsor: ara Hospital Kinki University Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-28
• Study Completion: 2014-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

(1) History of other malignancy,except for curatively treated carcinoma in situ or intramucosal carcinoma (Subjects with other malignancies who have been disease-free for at least 5 years are eligible.) (2) Patients who have undergone radiotherapy (3) Patients with diarrhea (4) Patient with regular use of furucytocin (5) Patients with severe complications,(severe cardiovascular disease,severe heart disease,heart failure,liver failure,renal failure or uncontrollable diabetes mellitus) (6) Patients with uncontrollable ascites and pleural effusion (7) The case suspected of infection with feaver (over 38 centigrade). (8) Serious drug hypersensitivity (9) Patients with paralytic ileus, bowel obstruction (10) Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. (11) Any other cases who are regarded as inadequate for study enrollmet by investigators

Study & Design

• Study Type: Interventional
• Study Design: Not specified